BEONE MEDICINES LTD. Noncontrolling Interest, Increase from Subsidiary Equity Issuance
BEONE MEDICINES LTD. (ONC) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $4.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-28.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2022-02-28
- BEONE MEDICINES LTD. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2019-06-30 was $4.00M.
- BEONE MEDICINES LTD. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2018-09-30 was $0.00.
- BEONE MEDICINES LTD. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2018-06-30 was $0.00.
- BEONE MEDICINES LTD. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2018-03-31 was $757.59M.
- BEONE MEDICINES LTD. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2019 was $4.00M.
- BEONE MEDICINES LTD. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2017 was $14.53M.
| Period end | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 3 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 6 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 9 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month |
|---|---|---|---|---|
| 2019-12-31 | $4.00M 10-K · filed 2022-02-28 | |||
| 2019-06-30 | $4.00M 10-Q · filed 2020-11-05 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $757.59M 10-Q · filed 2018-11-08 | $583.60M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $757.59M 10-Q · filed 2018-08-09 | $583.60M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2018-03-31 | $757.59M 10-Q · filed 2018-05-09 | $583.60M derived: sum of 2 quarters · filed 2020-03-02 | ||
| 2017-12-31 | -$173.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $14.53M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $188.52M 10-Q · filed 2017-11-13 |